Bioniche Gets FDA Warning Letter on Sotradecol Promotions

Generic Line
A A
Bioniche Pharma has received a warning letter from the FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) for a series of websites promoting its varicose vein treatment Sotradecol.

To View This Article:

Login

Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $10.00